Key Emphasis: How to Profit from Disruptive Changes in Healthcare and Finance
NEW YORK--(BUSINESS WIRE)--Jun 4, 2012-- OneMedPlace announced today
that its 3rd Annual 'OneMedForum NY' will include sessions on how
dramatic changes in regulation, through the passing of the JOBS Act,
will create opportunities for investors and entrepreneurs. The
conference will also feature expert panels in the most promising areas
of healthcare and life science investment followed by company
"With the passage of the JOBS Act over 70 years of securities
regulation has changed. When coupled with health reform and advances
in digital technology changing how healthcare is delivered, we are at
a period of historic risk and opportunity for investors and
entrepreneurs," said Brett Johnson, President of OneMedPlace. "Our
objective is to provide unique insight and to connect promising
innovative companies with investors seeking outsized returns."
In addition to expert panels and workshops, the conference will
include presentations by almost 50 companies that are developing
technologies in the most promising areas of health and medicine,
including regenerative medicine, diagnostics, oncology, and consumer
health information. Investor guides that include a near comprehensive
list of companies and resources in these areas will also be provided
"We are inviting companies that represent investment opportunity and
whose innovations we think will impact the marketplace," said Brett
Johnson."These are companies that you would not likely see at typical
investment banking conferences."
A dedicated track on the JOBS Act will look at how changes to the
general solicitation rules (Regulation D) can change the capital
raising process. It will consider crowdfunding and how biotech and
medical device companies can use it as part of an overall strategy to
not only raise capital, but also galvanize global audiences of
individuals passionate about various areas of medicine.
Held one week after the rules on crowdfunding and general solicitation
are to be issued by the SEC, the event will include analysis by
leading experts and regulators on how the legislation will affect
capital raising. The conference will open with a reception on July
11th and a keynote address by David Weild IV, former NASDAQ ViceChair.
Mr. Weild's research played a fundamental role in the passage of the
JOBS Act, and his ongoing consultation with the SEC is expected to
shape the rules, particularly as related to IPOs.
OneMedResearch, which focuses on small public companies that are
significantly undervalued, will be sponsoring a public company track.
Public company presentations will also be streamed live on OneMedTV
beginning 9 am on July 12th.
'OneMedForum NY 2012' is targeted toward venture capital, family fund,
private equity, angel and corporate strategic investors. Sponsors
include Ronald Trahan Associates Inc. ('RTA'), Grant Thornton, Greater
Zurich Area AG, MPR Associates, AdvaMed2012, Torreya Partners,
Association for Corporate Growth New York (ACG), EdgeTech Law LLP,
Aptiv Solutions, International Venture Club, New York Venture Capital
Association, New York Biotechnology Association, Reed Smith, Medmarc,
BDO, and Lincoln Park Capital.
OneMedPlace is a research and media organization building a virtual
community that connects emerging companies seeking capital,
distribution, and visibility with investors and strategic partners
looking for health and medical innovations to invest in, acquire,
license, distribute, purchase or utilize.
Established in 2008, OneMedForumis the conference component of
OneMedPlace, which provides an integrated media platform to showcase
the best ideas and innovations in health and medicine globally. The
media platform also includes: OneMedRadio; OneMedTV, OneMedSentinel; a
global database of companies; and OneMedResearch, which tracks
promising lesser-known microcap public companies.
Herina Ayot, +212-734-1008
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK
INDUSTRY KEYWORD: HEALTH PUBLIC POLICY/GOVERNMENT HEALTHCARE REFORM OTHER HEALTH PROFESSIONAL SERVICES FINANCE
Copyright Business Wire 2012
PUB: 06/04/2012 11:56 AM/DISC: 06/04/2012 11:56 AM